首页|盐酸氨溴索联合抗生素治疗支原体肺炎患儿的疗效及对血清炎性因子水平的影响

盐酸氨溴索联合抗生素治疗支原体肺炎患儿的疗效及对血清炎性因子水平的影响

扫码查看
目的 探究支原体肺炎(mycoplasma pneumoniae pneumonia,MPP)患儿接受盐酸氨溴索联合阿奇霉素治疗的效果.方法 非随机选取2023年6-12月丹阳市妇幼保健院收治的600例患儿为研究对象.按治疗方法不同分为对照组与观察组,每组300例.对照组给予阿奇霉素,观察组给予盐酸氨溴索联合阿奇霉素.比较两组疗效、临床症状改善时间、炎性因子及不良反应.结果 观察组总有效率为98.00%(294/300),高于对照组的95.00%(285/300),差异有统计学意义(χ2=3.997,P<0.05).治疗后,观察组临床症状改善时间短于对照组,血清炎性因子水平低于对照组,差异有统计学意义(P均<0.05).观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05).结论 盐酸氨溴索联合抗生素治疗可提高临床疗效,有效缓解MPP患儿临床症状,安全性较高.
Efficacy of Ambroxol Hydrochloride Combined with Antibiotics in the Treatment of Children with Mycoplasma Pneumonia and Its Effect on Se-rum Inflammatory Factor Levels
Objective To investigate the efficacy of ambroxol hydrochloride combined with azithromycin in the treat-ment of children with mycoplasma pneumoniae pneumonia(MPP).Methods A total of 600 children admitted to Dan-yang Maternal and Child Health Hospital from June to December 2023 were non-randomly selected as study subjects.According to different treatment methods,they were divided into control group and observation group,with 300 cases in each group.Azithromycin was given to the control group,and Ambroxol hydrochloride combined with azithromycin was given to the observation group.The efficacy,clinical symptoms improvement time,inflammatory factors and ad-verse reactions of the two groups were compared.Results The total effective rate of the observation group was 98.00% (294/300),which was higher than 95.00%(285/300)of the control group,and the difference was statistically signifi-cant(χ2=3.997,P<0.05).After treatment,the observation group's clinical symptoms improvement time were shorter than those of the control group,and the serum inflammatory factors levels were lower than those of the control group,and the differences were statistically significant(all P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion Ambroxol hydrochloride combined with antibiotic treatment can improve the clinical efficacy and effectively alleviate the clinical symptoms of children with MPP,with high safety.

Mycoplasma pneumoniaAmbroxol hydrochlorideAzithromycinClinical symptomsInterleukin-6C-reactive protein

杨云华

展开 >

丹阳市妇幼保健院药剂科,江苏 丹阳 212300

支原体肺炎 盐酸氨溴索 阿奇霉素 临床症状 白细胞介素6 C反应蛋白

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(17)